We had the pleasure of participating in the event organized by ORT Uruguay, which brings together key players in Uruguay’s biotech innovation ecosystem. Juan Manuel Valle shared our experience transitioning from fundamental science to the development of new therapies through cellular reprogramming.

We are seeking a researcher with a completed postgraduate degree. Application deadline: August 2nd, 2024.

Reprogramming bacteria to treat colorectal cancer. Felipe Trajtenberg shares everything about Locbio on the radio program En Perspectiva.

Reprogramming bacteria to fight cancer. Felipe Trajtenberg shares everything about Locbio’s objectives.

The Uruguayan newspaper spoke with the first four biotech start-ups funded by LAB+ about the challenges of developing a biotech company.

The Institut Pasteur of Montevideo introduced its Company Builder, LAB+. The founders of the first supported start-ups presented their projects. It is an honor to be part of LAB+ and to have had the opportunity for our founder, Felipe Trajtenberg, to present Locbio.